ClinicalTrials.gg

How we know

Every link on this study, and who decided it

The study on the left, the conditions and drugs this site links it to, and on each link the judgments that made or checked it, by day and by judge. The top row is the record itself: each new version seen since tracking began. Dashed lines are links the registry record does not make itself. Select a link to see everything judged on it, or a mark for one decision with its reason and evidence.

13 links0 made here, not in the record21 judgments2 judges (the rules as one: Rule based)0 record changes seen
Claude Opus 5.5Rule based
Oct 19Oct 26Nov 2Nov 9Nov 16TodayNCT04430738Tucatinib Plus Trastuzumaband Oxaliplatin-basedChemotherapy orPembrolizumab-containingCombinations for HER2+Gastrointestinal CancersSeagen, a wholly owned subsidiPhase 2 · active not recruitinRECORDThe record itselfVersions seen nightly since Sep 25, 2…›No new version seen since tracking began Sep 25, 2026.CONDITIONSColorectal NeoplasmsThe registry's MeSH filing›Nov 14 · Rule based · Finest filed termAs of now · Rule based · Main conditionMain conditionAdenocarcinoma Of EsophagusThe registry's MeSH filing›Nov 14 · Rule based · Finest filed termFinest filed termCholangiocarcinomaThe registry's MeSH filing›Nov 14 · Rule based · Finest filed termFinest filed termGallbladder NeoplasmsThe registry's MeSH filing›Nov 14 · Rule based · Finest filed termFinest filed termStomach NeoplasmsThe registry's MeSH filing›Nov 14 · Rule based · Finest filed termFinest filed termEsophageal NeoplasmsThe registry's MeSH filing›Nov 14 · Rule based · Wider: a narrower term is filedWider: a narrower term is filedDRUGSTucatinibIntervention entry›Nov 2 · Claude Opus 5.5 · TestedNov 18 · Rule based · BackgroundTestedTrastuzumabIntervention entry›Nov 2 · Claude Opus 5.5 · Background · establishedNov 18 · Rule based · BackgroundBackground · establishedOxaliplatinIntervention entry›Nov 2 · Claude Opus 5.5 · BackgroundNov 18 · Rule based · TestedBackgroundLeucovorinIntervention entry›Nov 2 · Claude Opus 5.5 · BackgroundNov 18 · Rule based · BackgroundBackgroundFluorouracilIntervention entry›Nov 2 · Claude Opus 5.5 · BackgroundNov 18 · Rule based · BackgroundBackgroundCapecitabineIntervention entry›Nov 2 · Claude Opus 5.5 · BackgroundNov 18 · Rule based · BackgroundBackgroundPembrolizumabIntervention entry›Nov 2 · Claude Opus 5.5 · BackgroundNov 18 · Rule based · TestedBackground

Times are in your time zone; a day marked “day only” kept no time. The graph scrolls sideways on a narrow screen; every mark is also in the list below.

Tucatinib

From the registry record2 judgments on this link
Role in the study, from the registry to what was judged
RegistryEntry “tucatinib”the record gives no role
→judged→changed
How the 2 judgments split50%of judgments with a known value say Tested
Tested · 1
Background · 1

All judgments on this study

WhenLinkJudgeDecisionState
Nov 2TucatinibClaude Opus 5.5TestedCurrent
Nov 2TrastuzumabClaude Opus 5.5Background · establishedCurrent
Nov 2OxaliplatinClaude Opus 5.5BackgroundCurrent
Nov 2LeucovorinClaude Opus 5.5BackgroundCurrent
Nov 2FluorouracilClaude Opus 5.5BackgroundCurrent
Nov 2CapecitabineClaude Opus 5.5BackgroundCurrent
Nov 2PembrolizumabClaude Opus 5.5BackgroundCurrent
Nov 14Colorectal NeoplasmsRule based · condition-kind ruleFinest filed termCurrent
Nov 14Adenocarcinoma Of EsophagusRule based · condition-kind ruleFinest filed termCurrent
Nov 14CholangiocarcinomaRule based · condition-kind ruleFinest filed termCurrent
Nov 14Gallbladder NeoplasmsRule based · condition-kind ruleFinest filed termCurrent
Nov 14Stomach NeoplasmsRule based · condition-kind ruleFinest filed termCurrent
Nov 14Esophageal NeoplasmsRule based · condition-kind ruleWider: a narrower term is filedCurrent
Nov 18TucatinibRule based · role ruleBackgroundOverridden
Nov 18TrastuzumabRule based · role ruleBackgroundAgrees
Nov 18OxaliplatinRule based · role ruleTestedOverridden
Nov 18LeucovorinRule based · role ruleBackgroundAgrees
Nov 18FluorouracilRule based · role ruleBackgroundAgrees
Nov 18CapecitabineRule based · role ruleBackgroundAgrees
Nov 18PembrolizumabRule based · role ruleTestedOverridden
As of nowColorectal NeoplasmsRule based · main-condition ruleMain conditionCurrent

The rules, in plain words

“Rule based” means one of these decided, not a model or a person. Each runs every night over every study.

Which drugs a study tests

Reads each treatment the study lists and the arms it is in. A drug only in the experimental arm is tested. A drug in every arm while something else changes between the arms is given beside it. A drug only in the control arm is the comparator. Placebo, procedures and usual care are known by name.

Where the whole record has been read, that reading's answer replaces the rule's.

What a study is mainly about

Starts from the first condition ClinicalTrials.gov files the study under. It moves to a narrower one only when the study's own title or listed conditions name it, and sets aside terms the registry often files by mistake. A study open to many cancers is not placed under one of them unless its title names it.

Checked against studies judged one by one; the study page says when it differs from the registry.

How a condition link is counted

For each condition a study is filed under: whether it is the study's own condition at the finest the study states it, a wider one, a general category, or filed by mistake; and whether it is the main condition, a setting the study names, or only how it was filed.

A decision on file for one study overrides it, with who made it and when.